ReviewAttention deficit and hyperactivity disorders2013

Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges.

Frank A López et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.